AbbVie
Manufacturing · Illinois, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
1 N Waukegan Rd, North Chicago, Illinois...Phone Number
(847) 932-7900Website
www.abbvie.comRevenue
$62.8 BillionStock Symbol
ABBVIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
5
4
5
3
2
About AbbVie
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.Explore more
AbbVie Org Chart
MR
Senior Financial Controller
FR
Controller
JC
Gulf-Levant Senior Financial Controller
SP
Financial Controller ( Abbvie , India)
FL
Financial Controller
GO
Controller
JF
Vice President, Commercial & Controller
YB
Controller
WM
Group Financial Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AbbVie your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if AbbVie has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once AbbVie has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when AbbVie launches new products
Check out if AbbVie is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at AbbVie
Click to see if AbbVie had a recent Job posting/layoffs
AbbVie, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on AbbVie recently announced quarterly report
Recommended Actions
Find VP level buyers at AbbVie
Find 3 more new buyers
Compare Similar Companies to AbbVie
Compare insights from companies similar to AbbVie, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$72.2B
10K+
Public
-
1876
KD
Kevin DuffinVice President, Chief Operating Officer, and Head of Core Technologies
$58.7B
10K+
Public
$4.7B
1999
DA
David AuerbachStrategy, Transformation Operations Leader & Global Chief Operating Officer, Head of Tmo, Oncology Research & Development
$48.5B
10K+
Public
$4B
1887
Joshua SugrimManager, Chief Technology Officer MSAT Process Validation - CAR T Cell Therapy
Company Profile Activity
Activity Insights
AbbVie is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AbbVie is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AbbVie.
AbbVie Tech Stack
A closer look at the technologies used by AbbVie
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
AbbVie News & Media
The 5 Most Interesting Analyst Questions From AbbVie’s Q2 Earnings Call
AbbVie’s second quarter results reflected robust product performance but were met with cautious investor sentiment. Management credited double-digit sales growth to strong execution in core immunology therapies, especially SKYRIZI and RINVOQ, and notable gains in the neuroscience portfolio. CEO Robert Michael emphasized that “each [portfolio] delivered growth above 20%,” with SKYRIZI achieving market leadership in multiple countries. However, the quarter also saw persistent biosimilar pressure oAbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie generates stronger free cash flow and trades at a lower forward multiple, while Abbott offers diversification and a healthier balance sheet.Analyst Report: AbbVie Inc
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
If approved, BOTOX® Cosmetic (onabotulinumtoxinA) would be the only neurotoxin with five aesthetic indications and the first and only approved for masseter muscle prominence in the U.S. Submission is supported by two Phase 3 studies (M21-416 and M21-417), demonstrating statistically...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AbbVie
Sign Up For FreeTo access detailed company insights
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outc... Read More
